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Background: Given the high prevalence of depression in primary health care (PHC), the use of screening
instruments has been recommended. Both brief and long depression screening instruments have been validated
in low and middle income countries (LMIC), including within HIV care settings. However, it remains unknown
whether the brief instruments validated in LMIC are as accurate as the long ones.
Methods: We conducted a search of PUBMED, the COCHRANE library, AIDSLINE, and PSYCH-Info from their
inception up to July 2011, for studies that validated depression screening instruments in LMIC. Data were extracted
into tables and analyzed using RevMan 5.0 and STATA 11.2 for the presence of heterogeneity.
Results: Nineteen studies met our inclusion criteria. The reported prevalence of depression in LMIC ranged from
11.1 to 53%. The area under curve (AUC) scores of the validated instruments ranged from 0.69-0.99. Brief as well as
long screening instruments showed acceptable accuracy (AUC≥0.7). Five of the 19 instruments were validated
within HIV settings. There was statistically significant heterogeneity between the studies, and hence a meta-analysis
could not be conducted to completion. Heterogeneity chi-squared = 189.23 (d.f. = 18) p<.001.
Conclusion: Brief depression screening instruments in both general and HIV-PHC are as accurate as the long ones.
Brief scales may have an edge over the longer instruments since they can be administered in a much shorter time.
However, because the ultra brief scales do not include the whole spectrum of depression symptoms including
suicide, their use should be followed by a detailed diagnostic interview.Background
Depression is a prevalent and disabling condition in both
high and low income countries [1-3]. According to the
World Health Organization, depression is the 4th most
disabling medical disorder, and is predicted to be the
2nd most disabling medical condition by 2020 [1,4]. The
12-month prevalence of depression has been reported
as 4.1%, with a lifetime prevalence of 6.7% [5].
Treatment guidelines developed in high income coun-
tries (HIC) recommend routine screening for depression
in primary health care (PHC) as an initial step in holistic* Correspondence: akenadickens@yahoo.co.uk
1Department of Psychiatry and Mental Health, University of Cape Town, Cape
Town, South Africa
2Department of Psychiatry, Makerere University, Kampala, Uganda
Full list of author information is available at the end of the article
© 2012 Akena et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orpatient care [6-8]. A number of brief (≤12 items) instru-
ments including the patient health questionnaire (PHQ-9)
[9,10] and the Kessler-10 (K-10) [11] have been validated
in low and middle income countries (LMIC). Similarly,
longer (≥15 items) instruments including the centre for
epidemiological studies-depression (CES-D) [12] have also
been validated in LMIC.
The bulk of research summarizing findings about the
accuracy of validated depression screening instruments
has come from HIC, providing conflicting data [13-15].
For example, one review found marginal differences
between brief and ultra-brief scales [14], while a meta-
analysis by Mitchell et al. (2007) reported that brief and
ultra-brief scales were equally accurate [15].
Generalizing findings from studies conducted in HIC
to LMIC may be inappropriate due to a number oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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patient numbers are some factors that are unique to
LMIC [3,16,17]. Such differences as low literacy rates
may influence the accuracy of depression screening
instruments, making the generalization of findings from
HIC to LMIC the more difficult.
Depression is a major health problem across LMIC;
however, a number of countries in sub-Saharan Africa
are equally plagued with a high burden of HIV/AIDS.
Indeed close to two thirds of all persons living with
HIV/AIDS (PLWHA), reside in sub-Saharan Africa [18].
Research has also shown that up to 30% of PLWHA
may develop depressive disorder during the course of
their illness [19,20].
The screening of depression among PLWHA is
important for a number of reasons; the presence of
symptom overlap between the two disorders being one
of them. For example, suicide, fatigue, sadness and
insomnia are symptoms reported by both PLWHA and
those with depression. The existence of symptom over-
laps call for screening PLWHA who present at PHC for
depression. Indeed a number of researchers have recom-
mended the routine screening of depression in PLWHA
[21-24]. However, literature about the validity of screen-
ing instruments in the setting of HIV/AIDS remains
scanty [25].
The aim of our systematic review was to examine the
accuracy of depression screening instruments which
have been validated in LMIC, comparing brief and long
scales. We also compared the accuracy of instruments
validated in general and HIV-PHC settings.
These findings could guide clinicians about which
scales to adapt for routine use in busy PHC settings
within LMIC.Methods
A literature search was conducted using the following
approach:
We searched the PUBMED, COCHRANE library,
AIDSLINE, and PSYCH-Info databases for studies pub-
lished in English from inception up to July 2011. In our
search, we used the following key words: sensitivity/
specificity, validation, depression/depressive disorders,
and screening instruments/tools/scales. These key words
were combined with LMIC, HIV/AIDS, Africa, Asia,
Eastern Europe, and South America. We then searched
reference lists from retrieved articles for suitable papers
and consulted two sets of authors [26,27] for more clar-
ity regarding data in their papers.Study selection
Studies were included if they had the following out-
comes of interest:1. A depression screening instrument followed by a
formal diagnostic instrument or an interview was
administered to all screened patients i.e. both
screen positive and negatives.
The diagnosis of a depressive disorder(major/minor/
dysthymia) was based on the ICD-10 [28], DSM-IV
[29], or an instrument frequently used as a gold
standard. Instruments routinely used to screen for
depression including the [30,31] were not considered
gold standard, even though a number of studies had
used them [25,32].
2. Studies were conducted in non-mental health facilities
3. Studies reported the sensitivity, specificity, the AUC
and predictive values of the screening instrument
in comparison to the diagnostic standard.
4. Studies were conducted in LMIC as defined by the
world bank [33].Data analysis
Data from included studies was extracted by one author
(DA) into tables constructed in MS Excel, and later
transferred to RevMan version 5.1.2 [34]. We used Rev-
Man to construct a diagnostic 2x2 table by calculating
the true positive, false positive, false negative and true
negative figures from the sensitivity/specificity and
prevalence values provided in all the included studies.
The figures from the 2x2 tables generated using RevMan
were then fitted in STATA version 11.2 [35] to assess for
heterogeneity using random effects analysis model.
Assessing for heterogeneity guided us, as to whether it
was possible to pool, analyze, and report the findings as
a meta-analysis. We used meta-analytic commands in
STATA for the analysis.Study quality assessment and inclusion
Data was independently abstracted by three authors
(DA, EO and TA). DA read all the abstracts, 1151 stud-
ies were excluded based on abstracts alone. Full articles
for 65 articles were identified for further scrutiny. Of the
65 articles identified for further scrutiny, 14 studies in
which 19 instruments were validated with 3759 partici-
pants met our criteria. See Figure 1.
Study inclusion and exclusion was independently done
by DA, EO and TA, in the event of ambiguity, DJS was
the arbitrator. We used RevMan to assess study quality.
The parameters assessed included blinding of reference
information from screening results, screening of patients
from highly selected populations, and selection of who
gets the gold standard from among a screened popula-
tion. Study quality was rated as fair, acceptable and good





1089 studies excluded because they
were not validated in LMIC.Some
were assessing both depression and
anxiety disorders concurrently
62 articles abstracted and 
read by authors
46 studies excluded mainly as a resul tof
inappropriate or ambiguous gold standard
administered to participants
19 articles fulfill the study
criteria
Figure 1 Study selection process for the systematic review.
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Of the 19 included studies, 10 fulfilled all the reporting
criteria by RevMan [30] and were considered of good
quality [26,36-42].One study was considered fair in qual-
ity due to the lack of blinding and referral of only screen
positives for the diagnosis from a highly selected popula-
tion [11]. The rest of the studies (n=8) were considered
acceptable. The studies with acceptable quality had lim-
ited information about blinding, some lacked clarity
about the time interval between administration of the
screening instrument and gold standard [27,43-47].
General description of studies
Eleven studies were conducted in Africa [11,26,27,38,40-
43,47], five of which were in HIV settings [26,27,38,
41,43]. Two studies were conducted in South America
[36,37] and six in Asia [39,44-46] The most frequently
used diagnostic instrument was the mini international
neuropsychiatric instrument (MINI) [48]. Table 1 below
shows the general characteristics of the studies. The sam-
ple sizes of included studies ranged from 61 to 649. The
prevalence of depression varied widely across populations
ranging from 11.1 to 53.5% (see Table 2 below). There
were also wide variations within continents, and also
according to the different instruments used. All validated
instruments were able to adequately identify depression,
with AUC ranging from 0.69-0.99. Table 2 above shows
the variables that were used to assess for heterogeneity.a)The BDI-SF, 1instrument
Leticia et al. (2005) [36] validated the BDI-SF
validated among 155 patients admitted to general
medical wards in Brazil. The gold standard was based
on the ICD-10 [28].
b)K-6, 1 instrument.
Tesfaye et al. (2009) validated the K-6 in 100
post natal women attending a general PHC
clinic in Ethiopia. A psychiatric interview based
on the DSM-IV [29] was used as the gold
standard.
c)K-10, 4 instruments
The K-10 was validated at four PHC sites, one of
which was an HIV PHC site. Fernandes et al. (2011)
[45] validated the K-10 among 194 pregnant
mothers at a rural prenatal clinic in India.
Meanwhile Spies et al. (2009) [27] validated the K-10
in 429 HIV-infected adults in an HIV care centre in
South Africa using the MINI as the gold standard.
Baggaley et al. (2007) [11] validated a translated
version of the K-10 in Burkina Faso among 61
women. A detailed diagnostic interview by a
psychiatrist within 3 days of administering the K10
was the gold standard. Tesfaye et al. (2009) validated
the K-10 in 100 post natal women attending a
general PHC clinic in Ethiopia. A psychiatric
interview based on the DSM-IV [29] was used as the
gold standard.
Table 1 General description of the studies included in the systematic review
Instrument Author Gold standard Participant characteristics Country of study
BDI-SF a Leaticia et al. (2005) ICD-10 Male/Female, in medical wards Brazil
EPDS b Chibanda et al. (2010) MINI Female, postnatal HIV-PHC Zimbabwe
EPDS b Lau et al. (2010) SCID Female, postnatal, general-PHC China
EPDS b Fernandes et al. (2011) MINI Female, antenatal, general-PHC India
EPDS a Figeuira et al. (2009) MINI Female, postnatal, general-PHC Brazil
EPDS b Tesfaye et al. (2009) DSM-IV Female,postnatal, general-PHC Ethiopia
CESD a Chisanga et al. (2011) MINI Male/Female HIV-PHC Zambia
CESD a Myer et al. (2008) MINI Male/Female HIV-PHC South Africa
K-6 a Tesfaye et al. (2009) DSM-IV Female,postnatal, general-PHC Ethiopia
K-10 c Baggeley et al. (2007) Psychiatrist Female, post natal, general-PHC Burkina
K-10 b Fernandes et al. (2011) MINI Female, antenatal, general-PHC India
K-10 b Spies et al. (2009) MINI Male/Female HIV-PHC South Africa
K-10 a Tesfaye et al. (2009) DSM-IV Female,postnatal, general-PHC Ethiopia
PHQ-9 a Lotrakul et al. (2008) SCID Male/Female Family practice clinic. Thailand
SRQ-20 a Stewart et al. (2009) MINI Female. Postnatal, General-PHC. Malawi
VAS b Puertas et al. (2004) CIS-R Male/Female General-PHC India
GHQ-10 b Puertas et al. (2004) CIS-R Male/Female General-PHC India
SWB-4 b Muwhezi et al. (2007) MINI Male/Female General-PHC Uganda
HSCL-25 a Kaaya et al. (2002) SCID Female, antenatal, HIV-PHC Tanzania
*a denotes study of good quality, *b acceptable quality, and *c denotes study of fair quality.
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The English language version of PHQ-9 was
translated into Thai by Lotraku et al. (2008) [39],
then back translated and adapted for use in Thailand.
The PHQ-9 was then validated among 280
participants in a general PHC setting in Thailand.
e) EPDS, 5 instruments.
The EPDS was the most validated instrument in both
pre and postnatal women. However, it should be
noted that women accessing antenatal and postnatal
care predominantly seek help for pregnancy related
complaints, and may differ from persons attending
general PHC. Despite such differences in the reason
for seeking help at PHC, studies report a 10-20%
prevalence of depression in postnatal women [49-51].
This high prevalence calls for the need to screen for
depression in this population. We also report about
these studies because such findings could be of
interest to persons involved in women’s mental
health research.
Fernandes et al. (2011) [45] validated the EPDS
among 194 women in their third trimester of
pregnancy at a rural prenatal clinic in Karnataka
India. The gold standard against which the EPDS was
validated was the ICD-10. In mainland China, Lau
et al. (2010) [44] validated the Chinese version of the
EPDS in 342 postnatal women, using the Structured
Clinical Interview for DSM-III-R (SCID) [52] as gold
standard.In Zimbabwe, Africa, Chibanda et al. (2010) [43]
validated the Shona version of EPDS scale among 210
postpartum HIV-infected and uninfected women
attending two primary care clinics in peri-urban
Harare, Zimbabwe. In Brazil, Figeuira et al. (2009) [37]
validated the EPDS in a sub-sample of 245 mothers;
the MINI was used as the gold standard.
Tesfaye et al. (2009) validated the EPDS in 100 post
natal women attending a general PHC clinic in
Ethiopia. A psychiatric interview based on the DSM-
IV [29] was used as the gold standard.
f ) Other brief (3) instruments
Puertas et al. (2004) [46] validated a visual analogue
scale (VAS) and the GHQ-10 among 450 participants
in India using the revised Clinical Interview Schedule
(CIS-R) [53] as a gold standard. The CIS-R is based
on the ICD-10 [28].
In Uganda, Muwhezi et al. (2007) [47] assessed the
validity of a 4- item subjective well-being subscale
(SWB) in detecting a major depressive illness. A total
of 199 consecutive patients were enrolled at a PHC
facility in Uganda, interviewed using the SWB and
the MINI [48] as a gold standard.
Longer scales
a) CES-D, 2 instruments
In Zambia, Africa, Chisanga et al. (2011) [38]
conducted a cross-sectional study in 16 primary level
Table 2 Parameters used to asses for heterogeneity of included studies
Instrument Author No. of subjects Prevalence Sensitivity Specificity AUC
BDI-SF Leaticia et al. (2005) 155 20 100 83.1 0.98
EPDS Chibanda et al. (2010) 210 30.4 88 87 0.82
EPDS Lau et al. (2010) 342 22.2 81.2 80.7 0.89
EPDS Fernandes et al. (2011) 194 14.4 100 84.9 0.95
EPDS Figeuira et al. (2009) 245 26.9 86.4 91.1 0.94
EPDS Tesfaye et al. (2009) 100 11.0 78.9 75.3 0.85
CESD Chisanga et al. (2011) 659 13.1 73 76 0.78
CESD Myer et al. (2008) 465 13.3 79 61 0.75
K-6 Tesfaye et al. (2009) 100 11.0 82.4 82.7 0.86
K-10 Baggeley et al. (2007) 61 43.3 74 76 0.77
K-10 Fernandes et al. (2011) 194 14.4 100 81.3 0.95
K-10 Spies et al. (2009) 425 53.3 67 77 0.77
K-10 Tesfaye et al. (2009) 100 11.2 84.2 77.8 0.87
PHQ-9 Lotrakul et al. (2008) 280 6.78 84 77 0.89
SRQ-20 Stewart et al. (2009) 114 30.5 59.2 85.4 0.85
VAS Puertas et al. (2004) 450 48.5 75.5 63.3 0.69
GHQ-10 Puertas et al. (2004) 450 48.5 93.6 81.1 0.87
SWB-4 Muwhezi et al. (2007) 199 37.3 75.7 86.3 0.87
HSCL-25 Kaaya et al. (2002) 100 11.1 89 80 0.86
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who had tuberculosis and were starting ART.
Chisanga validated the CES-D against the MINI [48]
as gold standard.
Myer et al. (2008) [26] validated the CES-D among
465 participants individuals had enrolled into
HIV care in South Africa. He used the MINI as
gold standard.
b) SRQ-20, 1 instrument
In Malawi, Stewart et al. (2009) [40] validated
the Chichewa version of the Self Reporting
Questionnaire (SRQ) was validated among 114
subjects at a PHC site. This instrument went
through a process of forward and back translation.
c) Other long instruments
Kaaya et al. (2002) [41] validated the Hopkins
Symptom Checklist-25 (HSCL-25) among 99 women
who were pregnant and HIV positive in Tanzania.
The gold standard was the SCID [52].
Analysis for the presence of heterogeneity between
studies
We used the ‘meta’ commands of STATA to generate the
forest plots and assess for heterogeneity. The test for het-
erogeneity using a random effects analysis model yielded a
statistically significant result. Heterogeneity chi-squared =
189.23, p = 0.000 on 18 degrees of freedom.
Statistically significant heterogeneity meant we could
not continue with the meta-analysis and report the results
as pooled estimates.Discussion
We present the first systematic review comparing the
accuracies of brief and long depression screening instru-
ments which have been validated in LMIC settings. In
this review, we found evidence to show that within
LMIC, a number of depressed patients are identified
using screening instruments at PHC settings. The preva-
lence figures reported in the included studies also vary
widely across PHC settings within LMIC.
We found statistically significant heterogeneity between
studies and could not conduct a meta-analysis to the
end. The heterogeneity across studies could be the result
of methodological differences in validation of instru-
ments. For example, we found that a single instrument
could be validated using different reference standards,
producing different cut off scores and AUC scores. The
CESD and EPDS were such examples in our review
[26,38,43,45]. In addition, these studies were conducted
across continents and settings with different cultures,
languages and resources.
Both brief and longer scales showed moderate to high
accuracy, with AUC ranging from 0.69-0.99. Our review
found evidence to show that brief scales including the
PHQ-9, BDI-SF, K-6, K-10, EPDS, and GHQ-12 were as
accurate as the longer ones like the CES-D, HSCL, and
BDI. These findings are in agreement with previous
reviews which assessed the accuracy of depression
screening instruments in HIC [6,14]. For example, a
review of instruments validated in the Spanish language
reported overall sensitivity and specificity in the range of
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are generally considered of low accuracy, 0.70 to 0.90 as
having moderate accuracy, and those with AUC ≥ 0.90
as highly accurate [54,55]. Of the instruments studied,
the EPDS shows acceptable accuracy in detecting
depression among pre and post-natal women, which
was in agreement with a previous systematic review
[50]. Among HIV clinic populations, the HSCL-25 [41]
showed the highest sensitivity at 89%.
No single instrument was superior to another in our
review, perhaps due the relatively small number of stud-
ies with any particular instrument. Previous reviews that
have assessed diagnostic accuracy of depression instru-
ments were equally unable to recommend a single in-
strument for use in PHC [15,50].
Limitations
A number of limitations should be acknowledged. For
example, we did not include studies that were not pub-
lished in English. That said, our literature review did not
return any studies in other languages that appeared to
meet our inclusion criteria. While some studies pub-
lished in non-indexed journals may have escaped notice,
there has been an increase in indexed journals in LMIC
in recent years, and most studies of quality should there-
fore have been captured.
Secondly, we didn’t include in our review instruments
which had been used to screen for the whole range of
psychiatric morbidity, limiting our scope to those that
had been validated for depression only. The inclusion of
such scales which had screened for both depression and
anxiety disorders could have been more informative;
however, such criteria could have turned up numerous
studies which may have been difficult to synthesize.
Much as the K-10, GHQ and SRQ-20 instruments asses
for common mental disorders including anxiety, depres-
sion and psychological distress, we only included them if
they had been used to screen for depression.
Conclusion
Brief instruments are as accurate as the longer ones in
detecting depression in both general and HIV-PHC set-
tings. The brief nature of a screening instrument (BDI-
SF, PHQ-10, and K-10) gives it the edge over longer
scales like the CES-D due the short duration in which it
can be administered. However, the fact that ultra-brief
scales such the K-6 and BDI-SF don’t encompass a
whole range of depressive symptoms including suicide,
the use of such scales needs to be followed up with
detailed psychiatric diagnostic interviews. The K-6 was
shown to be as accurate as the K-10 in the study by
Tesfaye et al. (2009).
Other scales such as the EPDS may be the instrument
of choice in particular populations (e.g. postnatal mothers).Competing interest
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